Navigation Links
Methylphenidate 'normalizes' activation in key brain areas in kids with ADHD
Date:5/9/2013

Philadelphia, Pa. (May 9, 2013) The stimulant drug methylphenidate "normalizes" activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a review published in the May Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Studies using functional magnetic resonance imaging (fMRI) show increased activation of key brain areas after a dose of methylphenidate in young patients with ADHD, according to the systematic review by Constance A. Moore, PhD, and colleagues of the University of Massachusetts Medical School. They write, "In most cases, this increase 'normalized' activation of at least some brain areas to levels seen in typically developing children."

How Do ADHD Medications Affect the Brain in ADHD Patients?

In a research review, Dr Moore and colleagues identified nine previous studies using fMRI to study patterns of brain activation in response to a single dose of methylphenidate. Perhaps best known by the brand name Ritalin, methylphenidate is a common and effective treatment for ADHD. "Although methylphenidate has been shown to significantly improve the behavioral symptoms associated with ADHD, both the mechanism behind its therapeutic effect and its direct effects on brain function are unknown," the researchers write.

The studies evaluated methylphenidate-induced fMRI changes in various brain areas, as the participants performed different types of tasks. Most of the studies included adolescent boys with ADHD, along with matched groups of young people without ADHD.

Methylphenidate altered activation patterns in widely distributed areas of the brain in ADHD patients, the results showed. The main brain areas involved were the frontal lobes, the basal ganglia, and cerebellum: "Abnormalities in these regions have all been implicated in patients with ADHD," Dr Moore and coauthors write.

Different areas were activated during different types of fMRI tasks. Several studies assessed performance on "inhibitory control" tasksthe ability to control certain types of accustomed ("prepotent") responses. In three out of five studies, methylphenidate "at least partially normalized" brain activation in ADHD patients, compared to healthy young people.

Different Tasks Affect Different Brain Areas

A few studies showed similar normalization of brain responses with methylphenidate on tasks of selective attention and time perceptionalthough not on tasks evaluating working memory. Methylphenidate mainly affected activation in the frontal lobes during inhibitory control tasks. During selective attention tasks, a wider range of brain areas were affected.

Since none of the studies evaluated ADHD symptoms on and off methylphenidate, there was no way to link the changes in brain activation with clinical improvement. Brain activation patterns with methylphenidate differed for patients who were versus were not previously treated with stimulants for ADHD.

Patients with ADHD have "age-inappropriate frequency or severity of inattentive or hyperactive-impulsive behaviors," according to the authors. It affects about five percent of children worldwide, and a growing body of evidence suggests that ADHD persists throughout adolescence and into adulthood. Functional fMRI provides a safe, noninvasive way to study how stimulants like methylphenidate may act in the brain of ADHD patients.

The new analysis suggests that methylphenidate partially normalizes activation in key brain areas thought to be involved in ADHD. The studies "may provide evidence that methylphenidate facilitates the return of brain function in ADHD patients to, or close to, a typically functioning state," Dr Moore and colleagues write. They call for further research to confirm that methylphenidate-induced changes in specific brain areas are correlated with improvement in ADHD symptoms.


'/>"/>

Contact: Connie Hughes
connie.hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health
Source:Eurekalert

Related medicine news :

1. Girls with eating disorders regain healthy fatty acid levels when their weight normalizes
2. Research reveals new understanding of X chromosome inactivation
3. HPV in older women may be due to reactivation of virus, not new infection
4. Same protein that fires up cancer-promoting Erk also blocks its activation
5. Study Suggests Vaccine May Help Kids With Brain Cancer
6. Epilepsy Leads to More Brain Abnormalities Over Time
7. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
8. Why is traumatic brain injury increasing among the elderly?
9. Brain Falters Near End of Life, but Games, Puzzles Might Slow Decline
10. Dental X-Rays May Be Linked to Benign Brain Tumors
11. Nonsurgical Method to Measure Brain Pressure Shows Promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... 2017 , ... With a heatwave currently bearing down on Northern California pushing temperatures to the ... swimsuit ready is easy with laser hair removal. , The process of summer waxing ... routine when all you want to do is get out, dive in and cool off. ...
(Date:6/24/2017)... Tampa, Fla. (PRWEB) , ... June 24, 2017 ... ... Fla., is now offering genetic testing for medications in select Florida and Texas ... of pharmacogenomics. , This new application of genetic testing recognizes the role ...
(Date:6/24/2017)... York (PRWEB) , ... June 24, 2017 , ... ... the Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers ... evenings and weekends so that visits to the dentist fit into their patients’ ...
(Date:6/24/2017)... , ... June 24, 2017 , ... Doorknobs are for ... security, such as getting a guard dog or having an alarm system installed. But ... secure against forced entry. Yair Frenkel, owner of TX Premier Locksmith in Killeen, TX ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... is needed and will ultimately do significant harm to people with all chronic ... , "While it leaves in place the Affordable Care Act (ACA) requirement ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... June 6, 2017  Diplomat Specialty Infusion Group, a brand of ... to its Iowa location. The ... now features an ISO 7 cleanroom—the standard needed to compound ... a low level of pollutants. ... consumers and better serve our Iowa patients," ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences Ltd. ... specializing in the development of cannabinoid-based drugs, today ... company overview at three upcoming scientific and investor ... LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: